BOVA Global Logo

Appropriate antimicrobial use in foals -how do we combat antimicrobial resistance? (2024)

Overview

Bacterial infections and sepsis are very common in foals and sepsis is still considered the primary cause of foal death worldwide. Treatment of many foal conditions involves the use of antimicrobial drugs. However, the development of antimicrobial resistance is a major concern, and there is increasing evidence that this problem is increasing in foals. How do we balance the need to treat an individual foal against the pressure to reduce our overall antimicrobial use? What steps can we take to improve our use of antimicrobial drugs and reduce the development of resistance? These are some of the challenging questions that we will attempt to address during the webinar!

Outline:

1. Considerations for antimicrobial use in foals

2. What constitutes appropriate antimicrobial use?

3. Antimicrobial resistance in foals

4. How can we improve our own antimicrobial stewardship?

Presenters

Emily Floyd

Dr Emily Floyd, BVSc, DACVIM, MRCVS

RCVS Recognised Specialist in Equine Internal Medicine

Clinical Director, Rossdales Equine Hospital, Newmarket

Related

Bova Ovulating Drugs report: the deslorelin/hCG reliability (2024)

Predicting the time of ovulation is of great importance for efficient breeding management of mares…

Clinical evaluation of two products to hasten ovulation in cyclic mares (2024)

The aim of this investigation was to compare the effectiveness of Bova deslorelin and chorolon to…

Induction of Ovulation (2024)

Discover the efficacy of ovulation induction treatments in mares. Bova-supported study compares hCG…
Load More